跳至主要内容
临床试验/NCT00195273
NCT00195273已完成3 期

A Randomized Open-Label Study Comparing the Efficacy and Safety of Sirolimus Combined With Daclizumab, Mycophenolate and Corticosteroids vs Cyclosporine, Mycophenolate and Corticosteroids in Renal Allograft Recipients Receiving Kidneys From Older Donors

Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 61 人开始时间: 2004年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
61
主要终点
Mean Creatinine Clearance Rate

研究概览

简要总结

The purpose of this study is to compare the kidney function in patients who have received a transplanted kidney and were treated with the combination of sirolimus, daclizumab, mycophenolate and corticosteroids versus transplanted patients treated with cyclosporine, mycophenolate and corticosteroids.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Kidney transplantation
  • Donor must be at least 60 years old.

排除标准

  • Current systemic infection
  • Unstable angina or treatment for serious arrhythmia.
  • Cancer within the previous 5 years.

研究组 & 干预措施

1

Experimental

Sirolimus + Daclizumab + Mycophenolate + Corticosteroids

干预措施: sirolimus (Drug)

1

Experimental

Sirolimus + Daclizumab + Mycophenolate + Corticosteroids

干预措施: mycophenolate mofetil (Drug)

1

Experimental

Sirolimus + Daclizumab + Mycophenolate + Corticosteroids

干预措施: corticosteroids (Drug)

1

Experimental

Sirolimus + Daclizumab + Mycophenolate + Corticosteroids

干预措施: daclizumab (Drug)

2

Active Comparator

Cyclosporine + Mycophenolate + Corticosteroids

干预措施: cyclosporine (Drug)

2

Active Comparator

Cyclosporine + Mycophenolate + Corticosteroids

干预措施: mycophenolate mofetil (Drug)

2

Active Comparator

Cyclosporine + Mycophenolate + Corticosteroids

干预措施: corticosteroids (Drug)

结局指标

主要结局

Mean Creatinine Clearance Rate

时间窗: 12 months

Creatinine clearance is a measure of kidney function. Creatinine clearance rate is the volume of blood plasma that is cleared of creatinine by the kidneys per unit time. Creatinine clearance can be measured directly or estimated using established formulas. For this study, the creatinine clearance rate was calculated using the Nankivell formula. Normal values for healthy, young males are in the range of 100-135 ml/min and for females 90-125 ml/min. A low creatinine clearance indicates poor kidney function.

次要结局

  • Number of Patients With Acute Rejection(3 and 12 months)
  • Patient and Graft Survival(12 months)
  • Mean Creatinine Clearance Rate - 3 Months(3 months)

研究者

发起方
Wyeth is now a wholly owned subsidiary of Pfizer
申办方类型
Industry

相似试验